
19.24 Delayed Data As of Dec 01 | ![]() Today’s Change | 13.82 Today|||52-Week Range 24.21 | +32.60% Year-to-Date |
What's Driving Twist Bioscience Corp's Surprising 14% Stock Rally? Nov 29 / GuruFocus News - Paid Partner Content | Myriad Genetics (MYGN) Expands Pharma Services With New Pact Nov 20 / Zacks.com - Paid Partner Content |
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now Nov 21 / Zacks.com - Paid Partner Content |
Previous close | 19.09 |
Today’s open | 18.72 |
Day’s range | 18.66 - 19.27 |
Volume | 16,294 |
Average volume (3 months) | 589,986 |
Market cap | $1.7B |
Earnings growth (last year) | -298.51% |
Earnings growth (this year) | -7.78% |
Earnings growth (next 5 years) | -68.57% |
Revenue growth (last year) | -1.77% |
P/E ratio | NM |
Price/Sales | 1.72 |
Price/Book | 1.76 |
Today’s change | Today’s % change | |
---|---|---|
CLDXCelldex Therapeutics... | +1.83 | +6.06% |
---- | ||
---- | ||
VCYTVeracyte Inc | +0.93 | +3.63% |
Next reporting date | February 28, 2024 |
EPS forecast (this quarter) | $0.04 |
Annual revenue (last year) | $678.4M |
Annual profit (last year) | -$112.0M |
Net profit margin | -16.51% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Salt Lake City, Utah |